Improved Radiosynthesis and Automation of [ 11 C]2‐(2,6‐Difluoro‐4‐((2‐( N ‐methylphenylsulfonamido)ethyl)thio)phenoxy)acetamide ([ 11 C]K2) for Positron Emission Tomography of the Glutamate α‐Amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole Propionic Acid (AMPA) Receptor
Journal of Labelled Compounds and Radiopharmaceuticals · 2024
DOI: 10.1002/jlcr.4113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, 2024. Verfasst von Jason A Witek und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University of Michigan Medical School, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Radiopharmaceuticals, Carbon Radioisotopes, Acetamides. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIBIB NIH HHS, Michigan Postdoctoral Pioneer Program at the University of Michigan Medical School, NIH HHS.
Abstract (Originalsprache)
A new automated radiosynthesis of [ 11 C]2‐(2,6‐difluoro‐4‐((2‐( N ‐methylphenylsulfonamido)ethyl)thio)phenoxy)acetamide ([ 11 C]K2), a radiopharmaceutical for the glutamate α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole propionic acid (AMPA) receptor, is reported. Although manual syntheses have been described, these are unsuitable for routine production of larger batches of [ 11 C]K2 for (pre)clinical PET imaging applications. To meet demands for the imaging agent from our functional neuroimaging collaborators, herein, we report a current good manufacturing practice (cGMP)‐compliant synthesis of [ 11 C]K2 using a commercial synthesis module. The new synthesis is fully automated and has been validated for clinical use. The total synthesis time is 33 min from end of bombardment, and the production method provides 2.66 ± 0.3 GBq (71.9 ± 8.6 mCi) of [ 11 C]K2 in 97.7 ± 0.5% radiochemical purity and 754.1 ± 231.5 TBq/mmol (20,382.7 ± 6256.1 Ci/mmol) molar activity ( n = 3). Batches passed all requisite quality control testing confirming suitability for clinical use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
- Department of Chemistry, University of Michigan, Ann Arbor, Michigan, USA.
ORCID-Profile: Jason A Witek, Mami Horikawa, Allen F Brooks, Peter J H Scott
Förderung
- NIBIB NIH HHS
- Michigan Postdoctoral Pioneer Program at the University of Michigan Medical School
- NIH HHS
- National Institutes of Health
Zitieren
APA
Witek, J. A., Horikawa, M., Henderson, B. D., Brooks, A. F., Scott, P. J. H., & Shao, X. (2024). Improved Radiosynthesis and Automation of [ 11 C]2‐(2,6‐Difluoro‐4‐((2‐( N ‐methylphenylsulfonamido)ethyl)thio)phenoxy)acetamide ([ 11 C]K2) for Positron Emission Tomography of the Glutamate α‐Amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole Propionic Acid (AMPA) Receptor. Journal of Labelled Compounds and Radiopharmaceuticals. https://doi.org/10.1002/jlcr.4113
Vancouver
Witek JA, Horikawa M, Henderson BD, Brooks AF, Scott PJH, Shao X. Improved Radiosynthesis and Automation of [ 11 C]2‐(2,6‐Difluoro‐4‐((2‐( N ‐methylphenylsulfonamido)ethyl)thio)phenoxy)acetamide ([ 11 C]K2) for Positron Emission Tomography of the Glutamate α‐Amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole Propionic Acid (AMPA) Receptor. Journal of Labelled Compounds and Radiopharmaceuticals. 2024. doi:10.1002/jlcr.4113
BibTeX
@article{Witek2024,
author = {Witek, Jason A and Horikawa, Mami and Henderson, Bradford D and Brooks, Allen F and Scott, Peter J H and Shao, Xia},
title = {Improved Radiosynthesis and Automation of [ 11 C]2‐(2,6‐Difluoro‐4‐((2‐( N ‐methylphenylsulfonamido)ethyl)thio)phenoxy)acetamide ([ 11 C]K2) for Positron Emission Tomography of the Glutamate α‐Amino‐3‐hydroxy‐5‐methyl‐4‐isoxazole Propionic Acid (AMPA) Receptor},
journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
year = {2024},
doi = {10.1002/jlcr.4113}
}
EUVIMED